News

In partnership with The Cancer Imaging Archive (TCIA), the American Association of Physicists in Medicine released a special virtual issue of Medical Physics in March 2021 titled, “Datasets Hosted in NCI’s Cancer Imaging Archive.” This special issue aims to highlight valuable examples of both Medical Physics Data Set Articles (MPDAs) and publicly available data sets that can be reused for future research endeavors and utilized for addressing emerging scientific or clinical questions.

New cancer genomic data sets from the Count Me In, Clinical Proteomic Tumor Analysis Consortium, and Human Cancer Models Initiative projects are now available through NCI’s Genomic Data Commons.

Attending the 2021 American Association for Cancer Research (AACR) Annual Meeting? Here are a few event and poster sessions you won’t want to miss to learn more about the latest NCI data science, data commons, and cancer research activities.

NIH’s National Library of Medicine recently released a Request for Information (RFI) on the use of Common Data Elements (CDEs) in the context of research on COVID-19. These comments will be used to inform NIH’s continuing development of guidance on CDE use for COVID-related research. RFI responses are due by May 10, 2021.

The U.S. Department of Health and Human Services has launched the “COVID-19 TOPx” technology sprint to develop digital solutions for the effective collection and reporting of COVID-19 diagnostics data. Data scientists, cancer researchers, and the greater public may provide feedback on these solutions in a live virtual demo on April 1, 2021.

The Childhood Cancer Data Initiative invites researchers capable of performing molecular characterizations (e.g., whole exome sequencing, RNA sequencing) to submit a proposal to develop a childhood cancer molecular characterization protocol by April 12, 2021.

The Pediatric Genomic Data Inventory (PGDI) is now available on datascience.cancer.gov for data scientists and cancer researchers. This resource lists known ongoing and completed sequencing projects of pediatric cancer cohorts from the United States and other countries, along with some basic details and reference metadata.

Clinical Proteomic Tumor Analysis Consortium (CPTAC) researchers from the Nesvizhskii Lab at the University of Michigan have developed an extension of its MSFragger flagship software to identify N- and O-linked glycopeptides.

NCI’s Office of Cancer Genomics’ data analysis and experimental observations tool—CTD² Dashboard—aims to make cancer-relevant results from the CTD² Network easier to use. Learn more about recent improvements to the Dashboard.

The Human Cancer Models Initiative’s (HCMI’s) Searchable Catalog now has new features that allow users to easily locate models and their case-associated data in the Genomic Data Commons.